Abstract: Accelerating matrix multiplication is crucial to achieve high performance in many application domains, including neural networks, graph analytics, and scientific computing. These ...

Abstract: An improved variant of the precise-integration time-domain (PITD) method is proposed to eliminate the inverse matrix calculation and optimize the storage burden with the help of sparse ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...